OVERVIEW

Cancer treatment has evolved significantly over the past decade from a treatment paradigm anchored on surgery, chemotherapy, and radiotherapy, to one embracing molecularly-targeted therapies disrupting tumor-specific signaling pathways, as well as new approaches to mobilize the immune system. For clinicians trying to keep current with advancing immuno-oncology principles and research, the pace of these developments has brought new challenges. Recognizing these challenges, this course will provide a comprehensive clinical review of the advances taking place in the immuno-oncology field.

The course is designed to enhance learners’ competence and performance in practice and will engage learners through interactive Q&A sessions with the faculty, along with didactic presentations.

LEARNING OBJECTIVES

Upon completion of this activity, participants will be able to:

TARGET AUDIENCE

This course is targeted to Specialty Physicians, Physician Assistants and Nurse Practitioners. This course may also be of interest to physicians who practice in Allergy and Immunology, Other, Oncology and Hematology
Radiation Oncology, Surgical Oncology and Immuno-Oncology.

ACCREDITATION

The Harvard Medical School is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The Harvard Medical School designates this live activity for a maximum of 9.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

For more information please visit the official event page.